在BRCA1突变癌症中,LIG1是一个合成致命的目标
Lauren Catherine M Martires1, Leanne G Ahronian1, Charlotte B Pratt1
1Tango Therapeutics Inc., Boston, Massachusetts.
Molecular cancer therapeutics
|January 27, 2025
概括
基因连接酶I (LIG1) 是一种新型的合成致命点,用于BRCA1突变癌症. 无活化LIG1可以选择性地杀死具有BRCA1突变的癌细胞,提供了一种超出PARP抑制剂的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 对BRCA1/2-突变癌症的合成致死性策略通常依赖于PARP抑制剂,面临患者显著的耐药性.
- 识别新型合成致命标对于克服这些癌症治疗耐药性的关键.
研究的目的:
- 确定和验证DNA结合酶I (LIG1) 作为BRCA1突变癌症中新型合成致命标.
- 研究BRCA1缺陷细胞中LIG1合成致死性的机制.
主要方法:
- 通过CRISPR/Cas9选来识别合成致命目标.
- 在体外验证使用CRISPRn,CRISPRi,RNAi和蛋白质降解来使LIG1.1无活化.
- 评估细胞活力,LIG1催化活性和DNA损伤标记物 (PAR染色).
- 使用异种移植模型进行体内验证.
主要成果:
- 克里斯普尔查确定了DNA结合酶I (LIG1) 作为BRCA1突变癌症中的合成致命标.
- 在BRCA1突变细胞系中,LIG1无活化选择性地降低了活力,但在BRCA1/2野生型细胞中却没有.
- LIG1的催化活性对于保持BRCA1突变细胞的活力至关重要.
- 在BRCA1突变细胞中LIG1的枯竭导致DNA损伤增加 (PAR染色) 和瘤静止体内.
结论:
- 基因链酶I (LIG1) 是BRCA1突变癌症的一个有希望的,有选择性的合成致命标.
- 向LIG1提供了一种潜在的治疗策略,以克服对PARP抑制剂等现有治疗方法的耐药性.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K


